Back to calendar
Repligen Corporation (RGEN) Earnings
RGEN reports earnings on Tuesday, November 3, 2026
earnings report
November 3, 2026 · Before Market Open
Q3 2026
Est. EPS: $0.46
Actual EPS: $0.54
EPS surprise: 20.79%
Company overview
Market Cap$10.2B
PriceUSD 180.98
P/E246.67
EPS (TTM)0.73
52-week high188.73
52-week low100.99
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees2,000